Z Geburtshilfe Neonatol 2020; 224(06): 348-354
DOI: 10.1055/a-1118-4084
Originalarbeit

Exzessive Gewichtszunahme in der Schwangerschaft und die prognostische Bedeutung des Apolipoprotein B

Does Apolipoprotein B Level in Early Pregnancy Predict Excessive Gestational Weight Gain and Adverse Pregnancy Outcome?
Sophia-Marie Bohlen
1   Klinik für Gynäkologie und Geburtshilfe, Universitätsklinikum Schleswig-Holstein Campus Kiel, Kiel
,
Christel Eckmann-Scholz
1   Klinik für Gynäkologie und Geburtshilfe, Universitätsklinikum Schleswig-Holstein Campus Kiel, Kiel
,
Werner Rath
1   Klinik für Gynäkologie und Geburtshilfe, Universitätsklinikum Schleswig-Holstein Campus Kiel, Kiel
,
Nicolai Maass
1   Klinik für Gynäkologie und Geburtshilfe, Universitätsklinikum Schleswig-Holstein Campus Kiel, Kiel
,
Ulrich Pecks
1   Klinik für Gynäkologie und Geburtshilfe, Universitätsklinikum Schleswig-Holstein Campus Kiel, Kiel
› Author Affiliations

Zusammenfassung

Einleitung Exzessive Gewichtszunahme (EGZ) stellt einen Risikofaktor in der Schwangerschaft dar. Da die EGZ ebenso wie Hypertensive Schwangerschaftserkrankungen (HES) und die intrauterine Wachstumsrestriktion (IUGR) mit veränderten Konzentrationen Apolipoprotein B- (ApoB) haltiger Lipoproteine einhergehen, wurde der Hypothese nachgegangen, ob die ApoB-Konzentration im ersten Trimester diese Ereignisse vorhersagen kann.

Methoden Von 547 Schwangeren zeigten 95 eine unzureichende, 171 eine empfohlene und 281 eine EGZ. 23 Schwangere wiesen eine HES, 67 ein small for gestational age (SGA) Neugeborenes und sieben eine IUGR auf. Die ApoB-Konzentration wurden mittels ELISA in Serum der 11+0 bis 13+6 SSW bestimmt.

Ergebnisse Die mittleren ApoB-Konzentrationen der Patientinnen verschiedener Gewichtszunahme-Gruppen waren nicht signifikant unterschiedlich. Frauen mit Adipositas zeigten höhere ApoB-Konzentrationen als normalgewichtige (p<0,001). Patientinnen mit präexistentem Hypertonus sowie Raucherinnen wiesen erhöhte ApoB-Konzentrationen verglichen mit normotensiven Kontrollen (p=0,0015) und Nichtraucherinnen (p=0,0118) auf. Eine prognostische Bedeutung ließ sich in Bezug auf HES und IUGR/SGA nicht nachweisen.

Folgerung Die ApoB-Konzentration im ersten Trimester ist nicht für die Vorhersage einer EGZ oder Schwangerschaftskomplikation geeignet. Bei bestehenden pathologischen Zuständen wie Rauchen, Adipositas und chronischer Hypertonie sind die ApoB-Werte erhöht und könnten in diesen Gruppen zur Pathogenese von Schwangerschaftserkrankungen beitragen.

Abstract

Introduction Excessive maternal gestational weight gain (GWG) is a risk factor for maternal and fetal complications. The lipid profile changes physiologically during pregnancy. Weight gain can affect lipid metabolism. The hypothesis of the study was that apoB levels early in pregnancy are associated with excessive GWG and predictive for adverse outcomes.

Methods Out of 547 patients there were 95 women with inadequate GWG, 171 with adequate GWG, and 281 with excessive GWG. Out of 581 patients there were 14 patients with pregnancy-induced hypertonus/pre-eclampsia, 67 with small-for-gestational-age (SGA) infants, and 7 with fetal growth restriction (FGR). ApoB levels were measured by ELISA.

Results There was no significant difference in apoB levels between the different GWG groups. We found significantly higher levels of apoB in overweight and obese patients compared to those with normal BMI. Smoking was correlated with higher apoB levels. There were no differences either between women with PIH/PE and normotensive women or between SGA/IUGR and pregnancies without. Women with pre-existing hypertension showed significantly higher apoB levels than the control group.

Conclusions ApoB cannot be used as a marker for identifying the risk of excessive GWG or adverse pregnancy outcomes early in pregnancy. However, it may be involved in the pathophysiology of adverse pregnancy outcomes in high-risk patients.



Publication History

Received: 19 July 2019

Accepted after revision: 04 February 2020

Article published online:
11 March 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • Literatur

  • 1 Koletzko B, Bauer C-P, Bung P. et al. Ernährung in der Schwangerschaft. Handlungsempfehlungen des Netzwerks „Gesund ins Leben – Netzwerk Junge Familie“. In: Jochum F Hrsg Ernährungsmedizin Pädiatrie. Infusionstherapie und Diätetik. Berlin, Heidelberg: Springer; 2013: 345-348 DOI: 10.1007/978–3–642–29817–2_32
  • 2 Goldberg GR, Prentice AM, Coward WA. et al. Longitudinal assessment of energy expenditure in pregnancy by the doubly labeled water method. Am J Clin Nutr 1993; 57: 494-505 DOI: 10.1093/ajcn/57.4.494.
  • 3 Abrams B, Altman SL, Pickett KE. Pregnancy weight gain. Still controversial. Am J Clin Nutr 2000; 71: 1233S-1241SS doi:10.1093/ajcn/71.5.1233s
  • 4 Kinnunen TI, Luoto R, Gissler M. et al. Pregnancy weight gain from 1960s to 2000 in finland. Int J Obes Relat Metab Disord 2003; 27: 1572-1577 DOI: 10.1038/sj.ijo.0802471.
  • 5 [Anonym] Committee Opinion, Number 548, January 2013, Weight gain during pregnancy, Reaffirmed 2015. Obstetrics & Gynecology 2013; 121: 210-212 DOI: 10.1097/01.AOG.0000425668.87506.4c.
  • 6 Kramer MS, Morin I, Yang H. et al. Why are babies getting bigger? Temporal trends in fetal growth and its determinants. J Pediatr 2002; 141: 538-542 DOI: 10.1067/mpd.2002.128029.
  • 7 Sridhar SB, Darbinian J, Ehrlich SF. et al. Maternal gestational weight gain and offspring risk for childhood overweight or obesity. Am J Obstet Gynecol 2014; 211: 259.e1-e8 DOI: 10.1016/j.ajog.2014.02.030.
  • 8 Opie RS, Neff M, Tierney AC. A behavioural nutrition intervention for obese pregnant women: effects on diet quality, weight gain and the incidence of gestational diabetes. Australian and New Zealand Journal of Obstetrics & Gynaecology 2016; 56: 364-373 doi:10.1111/ajo.12474
  • 9 Stefanović A, Kotur-Stevuljević J, Vujović A. et al. Association of the atherogenic index of plasma and oxidative stress status with weight gain during non-complicated pregnancy. Clin Chem Lab Med 2012; 50: 2019-2025 DOI: 10.1515/cclm-2012-0117.
  • 10 Hung T-H, Lo L-M, Chiu T-H. et al. A longitudinal study of oxidative stress and antioxidant status in women with uncomplicated pregnancies throughout gestation. Reproductive sciences 2010; 17: 401-409 DOI: 10.1177/1933719109359704.
  • 11 Macdonald-Wallis C, Tilling K, Fraser A. et al. Gestational weight gain as a risk factor for hypertensive disorders of pregnancy. Am J Obstet Gynecol 2013; 209: 327.e1-327.e17 DOI: 10.1016/j.ajog.2013.05.042.
  • 12 Hedderson MM, Gunderson EP, Ferrara A. Gestational weight gain and risk of gestational diabetes mellitus. Obstet Gynecol 2010; 115: 597-604 doi:10.1097/AOG.0b013e3181cfce4f
  • 13 Kaar JL, Crume T, Brinton JT. et al. Maternal obesity, gestational weight gain and offspring adiposity: the exploring perinatal outcomes among children study. J Pediatr 2014; 165: 509-515 DOI: 10.1016/j.jpeds.2014.05.050.
  • 14 Houghton LC, Ester WA, Lumey LH. et al. Maternal weight gain in excess of pregnancy guidelines is related to daughters being overweight 40 years later. Am J Obstet Gynecol 2016; 215: 246.e1-246.e8 DOI: 10.1016/j.ajog.2016.02.034.
  • 15 Gilmore LA, Klempel-Donchenko M, Redman LM. Pregnancy as a window to future health. Excessive gestational weight gain and obesity. Semin Perinatol 2015; 39: 296-303 doi:10.1053/j.semperi.2015.05.009
  • 16 McClure CK, Catov JM, Ness R. et al. Associations between gestational weight gain and BMI, abdominal adiposity, and traditional measures of cardiometabolic risk in mothers 8 y postpartum. Am J Clin Nutr 2013; 98: 1218-1225 DOI: 10.3945/ajcn.112.055772.
  • 17 Amorim AR, Rössner S, Neovius M. et al. Does excess pregnancy weight gain constitute a major risk for increasing long-term BMI?. Obesity 2007; 15: 1278-1286 DOI: 10.1038/oby.2007.149.
  • 18 Al Mamun A, Mannan M, O'Callaghan MJ. et al. Association between gestational weight gain and postpartum diabetes: evidence from a community based large cohort study. PLoS One 2013; 8: e75679 DOI: 10.1371/journal.pone.0075679.
  • 19 Diemert A, Lezius S, Pagenkemper M. et al. Maternal nutrition, inadequate gestational weight gain and birth weight: results from a prospective birth cohort. BMC Pregnancy Childbirth 2016; 16 DOI: 10.1186/s12884-016-1012-y.
  • 20 Siega-Riz AM, Viswanathan M, Moos M-K. et al. A systematic review of outcomes of maternal weight gain according to the Institute of Medicine recommendations: birthweight, fetal growth, and postpartum weight retention. Am J Obstet Gynecol 2009; 201: 339.e1-339.e14 DOI: 10.1016/j.ajog.2009.07.002.
  • 21 Walsh JM, McGowan CA, Mahony RM. et al. Obstetric and metabolic implications of excessive gestational weight gain in pregnancy. Obesity (Silver Spring) 2014; 22: 1594-1600 DOI: 10.1002/oby.20753.
  • 22 Lindberg S, Anderson C, Pillai P. et al. Prevalence and predictors of unhealthy weight gain in pregnancy. WMJ 2016; 115: 233-237
  • 23 Scholl TO, Chen X. Insulin and the “thrifty” woman. The influence of insulin during pregnancy on gestational weight gain and postpartum weight retention. Matern Child Health J 2002; 6: 255-261
  • 24 Scifres CM, Catov JM, Simhan HN. The impact of maternal obesity and gestational weight gain on early and mid-pregnancy lipid profiles. Obesity (Silver Spring) 2014; 22: 932-938 doi:10.1002/oby.20576
  • 25 Tal R, Taylor HS, Burney RO. et al. Endocrinology of pregnancy. In: Groot LJ de, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A eds. Endotext. South Dartmouth (MA): 2000
  • 26 Alvarez JJ, Montelongo A, Iglesias A. et al. Longitudinal study on lipoprotein profile, high density lipoprotein subclass, and postheparin lipases during gestation in women. J Lipid Res 1996; 37: 299-308
  • 27 Vahratian A, Misra VK, Trudeau S. et al. Prepregnancy body mass index and gestational age-dependent changes in lipid levels during pregnancy. Obstet Gynecol 2010; 116: 107-113 DOI: 10.1097/AOG.0b013e3181e45d23.
  • 28 Pecks U, Tillmann D, Ernst S. et al. Anti-oxidized low-density lipoprotein (oxLDL) antibody levels are not related to increasing circulating oxLDL concentrations during the course of pregnancy. American journal of reproductive immunology 2012; 68: 345-352 DOI: 10.1111/j.1600-0897.2012.01157.x.
  • 29 Wadsack C, Tabano S, Maier A. et al. Intrauterine growth restriction is associated with alterations in placental lipoprotein receptors and maternal lipoprotein composition. Am J Physiol Endocrinol Metab 2007; 292: E476-E484 DOI: 10.1152/ajpendo.00547.2005.
  • 30 Sattar N, Greer IA, Galloway PJ. et al. Lipid and lipoprotein concentrations in pregnancies complicated by intrauterine growth restriction. J Clin Endocrinol Metab 1999; 84: 128-130 DOI: 10.1210/jcem.84.1.5419.
  • 31 Pecks U, Caspers R, Schiessl B. et al. The evaluation of the oxidative state of low-density lipoproteins in intrauterine growth restriction and preeclampsia. Hypertens Pregnancy 2012; 31: 156-165 DOI: 10.3109/10641955.2010.544805.
  • 32 Cekmen MB, Erbagci AB, Balat A. et al. Plasma lipid and lipoprotein concentrations in pregnancy induced hypertension. Clin Biochem 2003; 36: 575-578 DOI: 10.1016/S0009-9120(03)00099-7.
  • 33 Amorim AR, Linné Y, Kac G. et al. Assessment of weight changes during and after pregnancy. Practical approaches. Matern Child Nutr 2008; 4: 1-13 DOI: 10.1111/j.1740-8709.2007.00093.x.
  • 34 Cartier L-J, Collins C, Lagacé M. et al. Comparison of fasting and non-fasting lipid profiles in a large cohort of patients presenting at a community hospital. Clin Biochem 2018; 52: 61-66 DOI: 10.1016/j.clinbiochem.2017.11.007.
  • 35 El Khouly NI, Sanad ZF, Saleh SA. et al. Value of first-trimester serum lipid profile in early prediction of preeclampsia and its severity. A prospective cohort study. Hypertens Pregnancy 2016; 35: 73-81 DOI: 10.3109/10641955.2015.1115060.
  • 36 Wölter M, Okai CA, Smith DS. et al. Maternal Apolipoprotein B100 Serum Levels are Diminished in Pregnancies with Intrauterine Growth Restriction and Differentiate from Controls. Proteomics Clin Appl 2018; 12: e1800017 DOI: 10.1002/prca.201800017.
  • 37 Contini C, Winkler BS, Maass N. et al. Concomitant intrauterine growth restriction alters the lipoprotein profile in preeclampsia. Pregnancy Hypertens 2019; 15: 154-160 DOI: 10.1016/j.preghy.2018.12.006.
  • 38 Sciarrone SG, Barden AE, Croft KD. et al. Plasma lipids and plasma and urinary acetyl hydrolase activity in normal and hypertensive pregnancies. Hypertens Pregnancy 1996; 15: 75-86 DOI: 10.3109/10641959609015690.
  • 39 AJJM Oostvogels, Busschers WB, EJM Spierings. et al. Pre-pregnancy weight status, early pregnancy lipid profile and blood pressure course during pregnancy. The ABCD study. PLoS One 2017; 12: e0177554 DOI: 10.1371/journal.pone.0177554.
  • 40 Wang C, Zhu W, Wei Y. et al. The associations between early pregnancy lipid profiles and pregnancy outcomes. Journal of Perinatology 2016; 1-7 DOI: 10.1038/jp.2016.191.
  • 41 Pu J, Romanelli R, Zhao B. et al. Dyslipidemia in special ethnic populations. Cardiol Clin 2015; 33: 325-333 DOI: 10.1016/j.ccl.2015.01.005.
  • 42 Howard BV, Ruotolo G, Robbins DC. Obesity and dyslipidemia. Endocrinol Metab Clin North Am 2003; 32: 855-867 doi:10.1016/S0889-8529(03)00073-2
  • 43 Thomas L. Labor und Diagnose. Indikation und Bewertung von Laborbefunden für die medizinische Diagnostik. 8. Aufl. Frankfurt: TH-Books; 2012
  • 44 Ben Ali S, Belfki-Benali H, Ahmed DB. et al. Postmenopausal hypertension, abdominal obesity, apolipoprotein and insulin resistance. Clinical and experimental hypertension 2016; 38: 370-374 DOI: 10.3109/10641963.2015.1131286.
  • 45 Onat A, Can G, Hergenç G. et al. Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation. International journal of obesity 2007; 31: 1119-1125 DOI: 10.1038/sj.ijo.0803552.
  • 46 Pecks U, Rath W, Caspers R. et al. Oxidatively modified LDL particles in the human placenta in early and late onset intrauterine growth restriction. Placenta 2013; 34: 1142-1149 DOI: 10.1016/j.placenta.2013.10.006.
  • 47 Ardalić D, Stefanović A, Kotur-Stevuljević J. et al. The influence of maternal smoking habits before pregnancy and antioxidative supplementation during pregnancy on oxidative stress status in a non-complicated pregnancy. Adv Clin Exp Med 2014; 23: 575-583
  • 48 Frondelius K, Borg M, Ericson U. et al. Lifestyle and dietary determinants of serum apolipoprotein A1 and apolipoprotein B Concentrations. Cross-sectional analyses within a swedish cohort of 24,984 individuals. Nutrients 2017; 9 DOI: 10.3390/nu9030211.
  • 49 Mankuta D, Elami-Suzin M, Elhayani A. et al. Lipid profile in consecutive pregnancies. Lipids Health Dis 2010; 9 DOI: 10.1186/1476-511X-9-58.
  • 50 Saker M, Soulimane Mokhtari N, Merzouk SA. et al. Oxidant and antioxidant status in mothers and their newborns according to birthweight. European journal of obstetrics&gynecology and reproductive biology 2008; 141: 95-99 DOI: 10.1016/j.ejogrb.2008.07.013.
  • 51 Cibičková Ľ, Karásek D, Langová K. et al. Correlation of lipid parameters and markers of insulin resistance. Does smoking make a difference?. Physiol Res 2014; 63 (Suppl. 03) 387-393
  • 52 Borenstein Ben Naftali Y, Solt I, Lowenstein L. et al. Gestational weight gain and its relationship with maternal characteristics. Isr Med Assoc J 2017; 19: 309-312
  • 53 Suliga E, Rokita W, Adamczyk-Gruszka O. et al. Factors associated with gestational weight gain. A cross-sectional survey. BMC Pregnancy Childbirth 2018; 18 DOI: 10.1186/s12884-018-2112-7.
  • 54 Tognon G, Berg C, Mehlig K. et al. Comparison of apolipoprotein (apoB/apoA-I) and lipoprotein (total cholesterol/HDL) ratio determinants. Focus on obesity, diet and alcohol intake. PLoS One 2012; 7: e40878 DOI: 10.1371/journal.pone.0040878.
  • 55 Mann S, Beedie C, Jimenez A. Differential effects of aerobic exercise, resistance training and combined exercise modalities on cholesterol and the lipid profile. Review, synthesis and recommendations. Sports Med 2014; 44: 211-221 doi:10.1007/s40279-013-0110-5
  • 56 Shipton D, Tappin DM, Vadiveloo T. et al. Reliability of self reported smoking status by pregnant women for estimating smoking prevalence. A retrospective, cross sectional study. BMJ 2009; 339: b4347 DOI: 10.1136/bmj.b4347.
  • 57 Truong YN, Yee LM, Caughey AB. et al. Weight gain in pregnancy. Does the institute of medicine have it right?. Am J Obstet Gynecol 2015; 212: 362.e1-8 DOI: 10.1016/j.ajog.2015.01.027.
  • 58 Deputy NP, Sharma AJ, Kim SY. et al. Prevalence and characteristics associated with gestational weight gain adequacy. Obstet Gynecol 2015; 125: 773-781 DOI: 10.1097/AOG.0000000000000739.
  • 59 Cheney K, Berkemeier S, Sim KA. et al. Prevalence and predictors of early gestational weight gain associated with obesity risk in a diverse australian antenatal population. A cross-sectional study. BMC Pregnancy Childbirth. 2017: 17 DOI: 10.1186/s12884-017-1482-6